EGOI-PCOS
  • The Group
    • Experts on Inositol
    • Experts on PCOS
    • Mission
    • Regulations and Statute
  • Clinical Centers
  • Publications
  • Activities
    • Fellowship
  • Affiliations
    • Support
  • Register
  • Login
Select Page

New clinical targets of d -chiro-inositol: rationale and potential applications

Jul 9, 2020

Authors: Antonio Simone Laganà, Simone Garzon and Vittorio Unfer

A double-edge sword: the role of D-chiro-inositol in oocyte and embryo quality

Dec 4, 2019

Authors: M. Minini, G. Monastra, S. Dinicola

Risk of reduced intestinal absorption of myo-inositol caused by D-chiro-inositol or by glucose transporter inhibitors

Aug 8, 2019

Authors: Garzon S, Laganà AS, Monastra G

The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios

Jun 9, 2019

Authors: M. Nordio, S. Basciani, E. Camajani

Inositol in Polycystic Ovary Syndrome: Restoring Fertility Through a Pathophysiology-Based Approach

Nov 2, 2018

Authors: Antonio Simone Laganà, Simone Garzon, Jvan Casarin, Massimo Franchi, Fabio Ghezzi
« Older Entries
Next Entries »


Viale di Villa Massimo 37, 00161, Rome (Italy)
Email: office@egoipcos.com or info@egoipcos.com
P.IVA / VAT ID: 96501700585

Subscribe to our Newsletter

Terms of use

Privacy and Cookie Policy
Registration Privacy Policy

All Rights Reserved ©2020 The Experts Group on Inositols in Basic and Clinical Research (EGOI)